next generation glp 1 drugs Next-Gen GLP-1 after Ozempic: Retatrutide to Orforglipron GLP-1 drugs: Foundayo and the
Description
The CEO of Novo Nordisk (NVO), the maker of Ozempic and Wegovy, said last year that food company executives were so scared they were calling him for advice on how to adapt to the new world of weight loss drugs
If you miss a dose of liraglutide (Victoza or Saxenda), take the next usual dose the next day
Sola-Leyva, A., Pathare, A.D.S., Apostolov, A., et al
doi:10.1126/science.299.5608.846 Authesserre N, et al
M.et al
